Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 24086539)

1.

Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele.

Anderson NM, Javadi M, Berndl E, Berberovic Z, Bailey ML, Huang K, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Carter-Su C, Wang C, McNagny KM, Paulson RF, Minden MD, Stanford WL, Barber DL.

PLoS One. 2013 Sep 25;8(9):e75472. doi: 10.1371/journal.pone.0075472. eCollection 2013.

2.

Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.

Srivastava AK, Kapur S, Mohan S, Yu H, Kapur S, Wergedal J, Baylink DJ.

J Bone Miner Res. 2005 Jun;20(6):1041-50. Epub 2004 Dec 27.

PMID:
15883645
3.

Novel small-eye allele in paired box gene 6 (Pax6) is caused by a point mutation in intron 7 and creates a new exon.

Puk O, Yan X, Sabrautzki S, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Graw J.

Mol Vis. 2013 Apr 12;19:877-84. Print 2013.

4.

ENU mutagenesis identifies the first mouse mutants reproducing human β-thalassemia at the genomic level.

Brown FC, Scott N, Rank G, Collinge JE, Vadolas J, Vickaryous N, Whitelaw N, Whitelaw E, Kile BT, Jane SM, Curtis DJ.

Blood Cells Mol Dis. 2013 Feb;50(2):86-92. doi: 10.1016/j.bcmd.2012.09.004. Epub 2012 Oct 2.

PMID:
23040355
5.

Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens.

Anderson NM, Berberovic Z, Berndl E, Bailey ML, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Wang C, Minden MD, McNagny KM, Paulson RF, Barber DL, Stanford WL.

Exp Hematol. 2012 Jan;40(1):48-60. doi: 10.1016/j.exphem.2011.09.007. Epub 2011 Sep 14.

6.

Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.

Akada H, Akada S, Hutchison RE, Mohi G.

Leukemia. 2014 Aug;28(8):1627-35. doi: 10.1038/leu.2014.52. Epub 2014 Jan 31.

8.

Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.

Michaud EJ, Culiat CT, Klebig ML, Barker PE, Cain KT, Carpenter DJ, Easter LL, Foster CM, Gardner AW, Guo ZY, Houser KJ, Hughes LA, Kerley MK, Liu Z, Olszewski RE, Pinn I, Shaw GD, Shinpock SG, Wymore AM, Rinchik EM, Johnson DK.

BMC Genomics. 2005 Nov 21;6:164.

9.

[ENU mouse mutagenesis and advanced reverse genetics].

Sakuraba Y, Gondo Y.

Tanpakushitsu Kakusan Koso. 2004 Dec;49(17 Suppl):2642-8. Review. Japanese. No abstract available.

PMID:
15669233
10.

Establishing an ENU mutagenesis screen for the piebald region of mouse Chromosome 14.

Hagge-Greenberg A, Snow P, O'Brien TP.

Mamm Genome. 2001 Dec;12(12):938-41. No abstract available.

PMID:
11707782
11.

A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.

Marty C, Lacout C, Droin N, Le Couédic JP, Ribrag V, Solary E, Vainchenker W, Villeval JL, Plo I.

Leukemia. 2013 Nov;27(11):2187-95. doi: 10.1038/leu.2013.102. Epub 2013 Apr 5.

PMID:
23558526
12.

Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs.

Duek A, Lundberg P, Shimizu T, Grisouard J, Karow A, Kubovcakova L, Hao-Shen H, Dirnhofer S, Skoda RC.

Blood. 2014 Jun 19;123(25):3943-50. doi: 10.1182/blood-2013-07-514208. Epub 2014 May 12.

13.

Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis.

Albiero E, Madeo D, Ruggeri M, Bernardi M, Giorgetti A, Rodeghiero F.

Br J Haematol. 2008 Sep;142(6):986-90. doi: 10.1111/j.1365-2141.2008.07180.x. Epub 2008 Jul 30.

PMID:
18671703
14.

An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.

Jablonski MM, Dalke C, Wang X, Lu L, Manly KF, Pretsch W, Favor J, Pardue MT, Rinchik EM, Williams RW, Goldowitz D, Graw J.

Mol Vis. 2005 Jul 27;11:569-81.

15.

Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.

Zaleskas VM, Krause DS, Lazarides K, Patel N, Hu Y, Li S, Van Etten RA.

PLoS One. 2006 Dec 20;1:e18.

16.

Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation.

Kamishimoto J, Tago K, Kasahara T, Funakoshi-Tago M.

Cell Signal. 2011 May;23(5):849-56. doi: 10.1016/j.cellsig.2011.01.009. Epub 2011 Jan 19.

PMID:
21255641
17.

An ENU-induced point mutation in the mouse Btaf1 gene causes post-gastrulation embryonic lethality and protein instability.

Wansleeben C, van Gurp L, de Graaf P, Mousson F, Marc Timmers HT, Meijlink F.

Mech Dev. 2011 May-Jun;128(5-6):279-88. doi: 10.1016/j.mod.2011.03.002. Epub 2011 Mar 16.

18.

JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.

Li J, Spensberger D, Ahn JS, Anand S, Beer PA, Ghevaert C, Chen E, Forrai A, Scott LM, Ferreira R, Campbell PJ, Watson SP, Liu P, Erber WN, Huntly BJ, Ottersbach K, Green AR.

Blood. 2010 Sep 2;116(9):1528-38. doi: 10.1182/blood-2009-12-259747. Epub 2010 May 20.

19.

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.

Ohyashiki JH, Yoneta M, Hisatomi H, Iwabuchi T, Umezu T, Ohyashiki K.

BMC Med Genet. 2012 Jan 17;13:6. doi: 10.1186/1471-2350-13-6.

20.

A new mouse limb mutation identifies a Twist allele that requires interacting loci on chromosome 4 for its phenotypic expression.

Blanc I, Bach A, Lallemand Y, Perrin-Schmitt F, Guénet JL, Robert B.

Mamm Genome. 2003 Dec;14(12):797-804.

PMID:
14724733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk